Welcome to the Jiang Lab
Welcome to the Jiang Lab
Engineering precision delivery systems for gene-editing therapies
Embedded Files
The Jiang Lab at UCLA develops non-viral delivery platforms to unlock the clinical potential of in vivo gene-editing therapies. Drawing on expertise in nanotechnology, biomolecular engineering, and immunology, we take a systematic, mechanism-driven approach to build delivery systems that are safe, efficient, and adaptable. Our goal is to equitably broaden access to curative therapies across a diverse spectrum of genetic disorders, from common conditions to the rarest n-of-1 diseases. Learn more about our research.
The Jiang Lab at UCLA will open its doors in July 2027! Stay tuned for more updates.
The Jiang Lab at UCLA will open its doors in July 2027! Stay tuned for more updates.
Our research group is based in the
News
2026
5/21/2026: Allen's postdoctoral work on AI-guided redesign of reverse transcriptases to enhance prime editing is out now in Nature Biotechnology.
3/10/2026: Allen is selected as an innovation and leadership delegate for the American Academy of Achievement's 2026 International Achievement Summit this June.
2025
4/15/2025: Allen is appointed Assistant Professor in the Chemical and Biomolecular Engineering department at UCLA effective July 1st, 2027.
Page updated
Report abuse